Literature DB >> 12534781

Emerging therapies of hepatitis B and C.

Robert Y M Chen1, Paul V Desmond, Stephen A Locarnini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12534781     DOI： 10.1046/j.1440-1746.17.s4.13.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  3 in total

1.  Loss of smell (anosmia) and taste (ageusia) in a patient treated with pegylated interferon alfa and ribavirin.

Authors:  Ahmed Yacoob Mayet
Journal:  Curr Ther Res Clin Exp       Date:  2007-07

2.  Nucleolar localization of human hepatitis B virus capsid protein.

Authors:  Bo Ning; Chiaho Shih
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 3.  "Anosmia" the mysterious collateral damage of COVID-19.

Authors:  Abdulrahman K Ahmed; Reem Sayad; Islam A Mahmoud; Aya M Abd El-Monem; Salma H Badry; Islam H Ibrahim; Mahmoud Hr Hafez; Mohamed A El-Mokhtar; Ibrahim M Sayed
Journal:  J Neurovirol       Date:  2022-03-05       Impact factor: 2.643
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.